A.R.T. Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

A.R.T. Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,590	Closed	-$404K	–	1079
2019 Q4	$404K	Buy	4,590 +100	+2%	+$8.43K	0.02%	927
2019 Q3	$339K	Buy	+4,490	New	+$364K	0.02%	1005
2019 Q2	–	Sell	-2,890	Closed	-$312K	–	1697
2019 Q1	$312K	Sell	2,890 -3,200	-53%	-$319K	0.02%	929
2018 Q4	$515K	Buy	6,090 +1,100	+22%	+$106K	0.03%	719
2018 Q3	$490K	Sell	4,990 -1,900	-28%	-$206K	0.02%	868
2018 Q2	$797K	Sell	6,890 -3,800	-36%	-$417K	0.03%	735
2018 Q1	$1.05M	Buy	10,690 +3,500	+49%	+$355K	0.04%	639
2017 Q4	$752K	Buy	+7,190	New	+$790K	0.03%	732
2016 Q2	–	Sell	-13,555	Closed	-$1.94M	–	1702
2016 Q1	$1.94M	Buy	13,555 +9,000	+198%	+$1.28M	0.09%	339
2015 Q4	$703K	Buy	+4,555	New	+$665K	0.03%	719
2015 Q3	–	Sell	-14,194	Closed	-$2.04M	–	1655
2015 Q2	$2.04M	Buy	14,194 +2,416	+21%	+$345K	0.07%	438
2015 Q1	$1.67M	Buy	+11,778	New	+$1.81M	0.06%	454
2014 Q2	–	Sell	-3,535	Closed	-$392K	–	1574
2014 Q1	$392K	Buy	+3,535	New	+$385K	0.02%	864

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

A.R.T. Advisors's TARO Position: Q1 2020 in Review

A.R.T. Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2020, closing a stake of 4,590 shares — an estimated $404K sold.

A.R.T. Advisors first reported a position in TARO in Q1 2014 and held it in 13 quarters. The position peaked at $2.04M in Q2 2015. 90 funds tracked by Wall St. Rank hold TARO as of Q1 2020.

A.R.T. Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2020 after selling out during the quarter.
A.R.T. Advisors sold 4,590 Taro Pharmaceutical Industries Ltd. shares in Q1 2020, an estimated $404K.
A.R.T. Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2014 and held it in 13 quarters.
A.R.T. Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $2.04M in Q2 2015.
90 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.